Can a loculated pleural effusion occur in a patient with congestive heart failure?

Yes, Loculated Pleural Effusions Can Occur in Congestive Heart Failure

While loculated pleural effusions are atypical for heart failure, they are well-documented and possible, though their presence should prompt consideration of alternative or coexisting diagnoses.

Understanding the Presentation

Heart failure-related pleural effusions are classically described as simple, free-flowing transudates that are typically bilateral. However, the 2024 European Respiratory Society guidelines explicitly acknowledge that septations and loculations can occur in heart failure effusions 1. The imaging characteristics shown in their diagnostic framework specifically illustrate that while transudates typically have an anechoic appearance on ultrasound, septations and loculations are recognized features 1.

Clinical Evidence

Historical case reports document loculated pleural effusions in heart failure, including:

• Subcostal loculated effusions presenting as "vanishing tumors" that resolved with diuretic therapy 2
• Interlobar loculated collections that disappeared with heart failure treatment 3

These cases demonstrate that loculation can occur in heart failure, though it remains uncommon.

Critical Diagnostic Approach

When you encounter a loculated effusion in a patient with known heart failure, you must actively investigate for alternative diagnoses 1. The 2024 ERS guidelines emphasize that:

Red Flags Suggesting Non-Cardiac Etiology:

• Complex pleural effusion on ultrasound (rather than simple)
• Weight loss
• Chest pain
• Fevers
• Elevated white cell count or C-reactive protein
• CT evidence of malignant pleural disease or infection
• Parietal pleural or diaphragmatic thickening/nodularity
• Absence of interstitial syndrome on thoracic ultrasound 1

Supportive Features for Cardiac Origin:

• Simple pleural effusion on ultrasound (despite loculation)
• Presence of interstitial syndrome
• Echocardiographic findings consistent with heart failure
• Elevated NT-proBNP ≥1500 μg/mL 1, 4
• Signs of elevated central venous pressure 1

Management Algorithm

For unilateral or loculated effusions in known heart failure patients 1:

1. First, assess clinical stability and red flags

   • If unstable OR red flags present → proceed to diagnostic thoracocentesis

2. If clinically stable without red flags:

   • Measure serum NT-proBNP (≥1500 μg/mL supports cardiac origin) 1, 4
   • Perform thoracic and cardiac ultrasound looking for:
     • Interstitial syndrome (supports cardiac)
     • Simple vs. complex effusion characteristics
     • Echocardiographic evidence of heart failure

3. If findings support cardiac origin:

   • Optimize heart failure treatment
   • Monitor clinical progress
   • Reassess if no improvement

4. If findings equivocal or suggest alternative diagnosis:

   • Proceed to diagnostic thoracocentesis to rule out malignancy, infection, or other causes

Important Caveats

The presence of loculation should lower your threshold for invasive investigation because:

• In one large series, 41% of heart failure patients with pleural effusions had unilateral presentations 1, which is already atypical
• Loculation is even more atypical than unilateral presentation
• Missing malignant pleural effusion or pleural infection carries significant morbidity and mortality 1

Common pitfall: Assuming all effusions in heart failure patients are cardiac in origin. The 2024 BTS guidelines note that multiple conditions may coexist, and serum biomarkers should not be used in isolation 4.

Key principle: While loculated effusions can occur in heart failure and may resolve with diuretic therapy 2, 3, their presence mandates a more thorough diagnostic evaluation than typical bilateral simple effusions would require.